Clifford Law Offices offers these free articles to help educate people about subjects such as Jury Objectivity and Fairness
Chicago, IL (PRWEB) April 22, 2009
A recent ruling by the Supreme Court of the United States is expected to have a profound impact on pharmaceutical and medical device litigation. In its decision, the Court held that Food and Drug Administration (FDA) approval of products and warning labels does not protect drug manufacturers from litigation in state courts. Previous to this ruling, drug companies relied on the defense that FDA approval preempted injury claims against them. In response to this ruling, bills have been sponsored in both the House and the Senate that would allow those injured by unsafe medical devices to bring a lawsuit in state court.
Robert Clifford, the nationally renowned personal injury attorney based out of Chicago, wrote about this Supreme Court ruling in a piece for the Chicago Lawyer. In 'A More Even Playing Field' Clifford explains how this recent opinion will affect the legal landscape for individuals injured by FDA approved medical or pharmaceutical products.
"Clifford Law Offices offers these free articles to help educate people about subjects such as Jury Objectivity and Fairness," says Robert A. Clifford, Founder.